[96a5a0]: / output / allTrials / identified / NCT04624373_identified.json

Download this file

241 lines (241 with data), 9.0 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
{
"info": {
"nct_id": "NCT04624373",
"official_title": "Molecular Analysis of the Surnantant of Echoguidated Bronchoscopic Cytopunctions in Lung Cancer",
"inclusion_criteria": "* Age > 18 years-old\n* Patients planned for an EBUS-TBNA for\n\n 1. Suspicion of stage IV lung cancer (PET+ mediastinal node(s)) (Cohort 1)\n 2. Stage IV NSCLC with an EGFR, BRAF, HER2, MET mutation or ALK, RET or ROS1 rearranged NSCLC and acquired resistance to targeted therapy (Cohort 2)\n* Performance status 0-3\n* Informed consent\nMust have minimum age of 18 Years\nMust have maximum age of 65 Years",
"exclusion_criteria": "* Refusal to participate\n* Patient under legal tutelage",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Age > 18 years-old",
"criterions": [
{
"exact_snippets": "Age > 18 years-old",
"criterion": "age",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": ">",
"value": 18,
"unit": "years-old"
}
}
]
}
]
},
{
"line": "* Patients planned for an EBUS-TBNA for",
"criterions": [
{
"exact_snippets": "planned for an EBUS-TBNA",
"criterion": "EBUS-TBNA procedure",
"requirements": [
{
"requirement_type": "planned",
"expected_value": true
}
]
}
]
},
{
"line": "1. Suspicion of stage IV lung cancer (PET+ mediastinal node(s)) (Cohort 1)",
"criterions": [
{
"exact_snippets": "Suspicion of stage IV lung cancer",
"criterion": "stage IV lung cancer",
"requirements": [
{
"requirement_type": "suspicion",
"expected_value": true
}
]
},
{
"exact_snippets": "PET+ mediastinal node(s)",
"criterion": "mediastinal node(s)",
"requirements": [
{
"requirement_type": "PET+",
"expected_value": true
}
]
}
]
},
{
"line": "2. Stage IV NSCLC with an EGFR, BRAF, HER2, MET mutation or ALK, RET or ROS1 rearranged NSCLC and acquired resistance to targeted therapy (Cohort 2)",
"criterions": [
{
"exact_snippets": "Stage IV NSCLC",
"criterion": "NSCLC stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": "IV"
}
]
},
{
"exact_snippets": "EGFR, BRAF, HER2, MET mutation",
"criterion": "genetic mutation",
"requirements": [
{
"requirement_type": "presence",
"expected_value": [
"EGFR",
"BRAF",
"HER2",
"MET"
]
}
]
},
{
"exact_snippets": "ALK, RET or ROS1 rearranged",
"criterion": "genetic rearrangement",
"requirements": [
{
"requirement_type": "presence",
"expected_value": [
"ALK",
"RET",
"ROS1"
]
}
]
},
{
"exact_snippets": "acquired resistance to targeted therapy",
"criterion": "resistance to therapy",
"requirements": [
{
"requirement_type": "acquired resistance",
"expected_value": true
}
]
}
]
},
{
"line": "* Performance status 0-3",
"criterions": [
{
"exact_snippets": "Performance status 0-3",
"criterion": "performance status",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 3,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "* Informed consent",
"criterions": [
{
"exact_snippets": "Informed consent",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
},
{
"line": "Must have maximum age of 65 Years",
"criterions": [
{
"exact_snippets": "maximum age of 65 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 65,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Refusal to participate",
"criterions": [
{
"exact_snippets": "Refusal to participate",
"criterion": "participation",
"requirements": [
{
"requirement_type": "willingness",
"expected_value": false
}
]
}
]
},
{
"line": "* Patient under legal tutelage",
"criterions": [
{
"exact_snippets": "Patient under legal tutelage",
"criterion": "legal tutelage",
"requirements": [
{
"requirement_type": "status",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}